Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > April 13, 2023
Daily News
April 13, 2023
- LDP Pharma Study Group to Draw Up Resolution in May before Honebuto Paper
April 13, 2023
- Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers
April 13, 2023
- PET Imaging Agent Vizamyl Filed for Additional Use for AD Modifying Drug
April 13, 2023
- European Pharma CEOs Prod Japan to Rethink Drug Pricing System: Forum
April 13, 2023
- Alexion Japan Recalling Ultomiris IV 300 mg/3 mL
April 13, 2023
- Japan Lacks Talent, Ecosystem to Incubate Drug Seeds: Chugai Chair
April 13, 2023
- Astellas, Kyoto University’s CiRA Extend iPS Cell Pact
April 13, 2023
- Lawmakers Split 50/50 on Abortion Pill, No Conclusion at LDP Panel
April 13, 2023
- Ultomiris’ NMOSD Nod Up for Advisory Panel Review on April 26
April 13, 2023
- Mpox Cases Top 100 in Japan, 10 New Patients Confirmed
April 13, 2023
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…